These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 7910879

  • 1. What is the best way to predict IDDM?
    Palmer JP.
    Lancet; 1994 Jun 04; 343(8910):1377-8. PubMed ID: 7910879
    [No Abstract] [Full Text] [Related]

  • 2. Combined antibody screening for improved prediction of IDDM--modern strategies.
    Roll U, Ziegler AG.
    Exp Clin Endocrinol Diabetes; 1997 Jun 04; 105(1):1-14. PubMed ID: 9088889
    [No Abstract] [Full Text] [Related]

  • 3. Islet autoantibodies and their use in predicting insulin-dependent diabetes.
    Bonifacio E, Bingley PJ.
    Acta Diabetol; 1997 Oct 04; 34(3):185-93. PubMed ID: 9401639
    [No Abstract] [Full Text] [Related]

  • 4. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R, Reijonen H, Vähäsalo P, Sabbah E, Kulmala P, Ilonen J, Akerblom HK, Knip M.
    J Clin Invest; 1996 Dec 01; 98(11):2489-95. PubMed ID: 8958211
    [Abstract] [Full Text] [Related]

  • 5. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M, Ziegler B.
    Z Arztl Fortbild (Jena); 1994 Aug 01; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract] [Full Text] [Related]

  • 6. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.
    Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamäki K, Stengård J, Rowley MJ.
    Lancet; 1994 Jun 04; 343(8910):1383-5. PubMed ID: 7910881
    [Abstract] [Full Text] [Related]

  • 7. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers.
    Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA.
    Diabetes; 1997 Nov 04; 46(11):1701-10. PubMed ID: 9356015
    [Abstract] [Full Text] [Related]

  • 8. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T, Nakanishi K, Okubo M, Murase T, Kosaka K.
    Diabetes Care; 1996 Sep 04; 19(9):1031. PubMed ID: 8875105
    [No Abstract] [Full Text] [Related]

  • 9. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
    Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG.
    Diabetes Care; 1997 Jun 04; 20(6):965-70. PubMed ID: 9167107
    [Abstract] [Full Text] [Related]

  • 10. Proposed guidelines on screening for risk of type 1 diabetes.
    Bingley PJ, Bonifacio E, Ziegler AG, Schatz DA, Atkinson MA, Eisenbarth GS, Immunology of Diabetes Society.
    Diabetes Care; 2001 Feb 04; 24(2):398. PubMed ID: 11213898
    [No Abstract] [Full Text] [Related]

  • 11. GADA positivity at onset of type 1 diabetes is a risk factor for the development of autoimmune thyroiditis.
    Kordonouri O, Charpentier N, Hartmann R.
    Pediatr Diabetes; 2011 Feb 04; 12(1):31-3. PubMed ID: 20723098
    [Abstract] [Full Text] [Related]

  • 12. Do GAD antibodies at IDDM onset predict the clinical course of diabetes in children?
    Kordonouri O, Danne T, Weber B.
    Diabetes Care; 1996 Aug 04; 19(8):901-2. PubMed ID: 8842617
    [No Abstract] [Full Text] [Related]

  • 13. Antibodies as predictors of insulin-dependent diabetes mellitus before the clinical onset.
    Tuomilehto J, Ylihärsilä H.
    Nutrition; 1998 Apr 04; 14(4):403-5. PubMed ID: 9591316
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J, Amann J, Mauch L, Haubruck H, Wolfahrt S, Bieg S, Richter W, Holl R, Heinze E, Northemann W.
    J Clin Invest; 1993 Sep 04; 92(3):1394-9. PubMed ID: 8376591
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Bottazzo GF.
    Diabetes; 1994 Oct 04; 43(10):1254-9. PubMed ID: 7926297
    [Abstract] [Full Text] [Related]

  • 16. Disease-associated antibodies in offspring of mothers with IDDM.
    Martikainen A, Saukkonen T, Kulmala PK, Reijonen H, Ilonen J, Teramo K, Koskela P, Knip M, Akerblom HK.
    Diabetes; 1996 Dec 04; 45(12):1706-10. PubMed ID: 8922355
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined analysis of IDDM-related autoantibodies in healthy schoolchildren.
    Genovese S, Bingley PJ, Bonifacio E, Christie MR, Shattock M, Bonfanti R, Foxon R, Gale EA, Bottazzo GF.
    Lancet; 1994 Sep 10; 344(8924):756. PubMed ID: 7915802
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous onset of type 1 diabetes in monozygotic twins younger than 1 year.
    Uchida N, Amano Y, Akazawa Y, Nakamura S, Minami I, Washizawa K, Wakabayashi Y, Yasui K.
    Eur J Pediatr; 2008 Feb 10; 167(2):161-3. PubMed ID: 17361417
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.